BNP PARIBAS ASSET MANAGEMENT Holding S.A. Decreases Position in Kenvue Inc. $KVUE

BNP PARIBAS ASSET MANAGEMENT Holding S.A. reduced its position in shares of Kenvue Inc. (NYSE:KVUE) by 9.3% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 722,929 shares of the company’s stock after selling 74,073 shares during the period. BNP PARIBAS ASSET MANAGEMENT Holding S.A.’s holdings in Kenvue were worth $11,733,000 at the end of the most recent quarter.

A number of other hedge funds have also made changes to their positions in the company. CWM LLC boosted its stake in shares of Kenvue by 6.6% in the second quarter. CWM LLC now owns 31,265 shares of the company’s stock worth $654,000 after acquiring an additional 1,923 shares during the last quarter. Allianz Asset Management GmbH lifted its holdings in Kenvue by 57.6% in the 2nd quarter. Allianz Asset Management GmbH now owns 45,368 shares of the company’s stock valued at $950,000 after purchasing an additional 16,580 shares in the last quarter. Phoenix Financial Ltd. purchased a new position in Kenvue in the 2nd quarter valued at $210,000. Whittier Trust Co. boosted its stake in Kenvue by 5.6% during the 2nd quarter. Whittier Trust Co. now owns 16,325 shares of the company’s stock worth $342,000 after purchasing an additional 871 shares during the last quarter. Finally, Cullen Frost Bankers Inc. boosted its stake in Kenvue by 7.8% during the 2nd quarter. Cullen Frost Bankers Inc. now owns 374,907 shares of the company’s stock worth $7,847,000 after purchasing an additional 27,118 shares during the last quarter. Institutional investors and hedge funds own 97.64% of the company’s stock.

Kenvue Stock Performance

Kenvue stock opened at $18.68 on Friday. The firm has a 50 day simple moving average of $17.51 and a 200-day simple moving average of $17.67. The stock has a market cap of $35.78 billion, a price-to-earnings ratio of 24.25 and a beta of 0.59. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.98 and a quick ratio of 0.69. Kenvue Inc. has a 1-year low of $14.02 and a 1-year high of $25.17.

Kenvue (NYSE:KVUE) last released its quarterly earnings data on Tuesday, February 17th. The company reported $0.27 EPS for the quarter, beating analysts’ consensus estimates of $0.22 by $0.05. The firm had revenue of $3.78 billion for the quarter, compared to analysts’ expectations of $3.68 billion. Kenvue had a return on equity of 19.86% and a net margin of 9.72%.The firm’s quarterly revenue was up 3.2% on a year-over-year basis. During the same period in the prior year, the firm posted $0.26 earnings per share. On average, analysts expect that Kenvue Inc. will post 1.14 EPS for the current year.

Kenvue Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, February 25th. Stockholders of record on Wednesday, February 11th will be issued a dividend of $0.2075 per share. The ex-dividend date is Wednesday, February 11th. This represents a $0.83 dividend on an annualized basis and a dividend yield of 4.4%. Kenvue’s dividend payout ratio is currently 110.67%.

Wall Street Analyst Weigh In

A number of equities research analysts have recently commented on the stock. Canaccord Genuity Group increased their target price on shares of Kenvue from $17.00 to $18.00 and gave the company a “hold” rating in a research report on Wednesday. Deutsche Bank Aktiengesellschaft set a $18.00 price objective on shares of Kenvue in a research note on Friday, October 24th. UBS Group increased their price objective on shares of Kenvue from $17.00 to $19.00 and gave the company a “neutral” rating in a report on Wednesday. Zacks Research upgraded Kenvue from a “strong sell” rating to a “hold” rating in a report on Wednesday, November 26th. Finally, Citigroup increased their price target on Kenvue from $18.00 to $20.00 and gave the company a “neutral” rating in a report on Wednesday. Four equities research analysts have rated the stock with a Buy rating and twelve have given a Hold rating to the company’s stock. According to data from MarketBeat.com, Kenvue currently has a consensus rating of “Hold” and a consensus price target of $20.08.

Insider Activity

In related news, Director Jeffrey C. Smith bought 3,200,000 shares of the firm’s stock in a transaction on Friday, December 12th. The shares were bought at an average price of $17.37 per share, with a total value of $55,584,000.00. Following the completion of the transaction, the director directly owned 27,307,632 shares of the company’s stock, valued at $474,333,567.84. This represents a 13.27% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 1.68% of the company’s stock.

About Kenvue

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.